Drizalma Sprinkle (Duloxetine HCl) Patent Expiration, LOE Window & CMS Spending

Drizalma Sprinkle (Duloxetine HCl) by Sun Pharmaceutical: FDA Orange Book LOE 2037-04-13, 16 AB generics, $1.4M 2024 CMS Part D & Medicaid spend, and 8 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorSun Pharmaceutical
FDA Application & PathwayN212516 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2037-04-13
Orange Book Patents (*PED Extensions)5 patents (0 *PED)
Active AB-Rated Generic Competitors16
2024 CMS Total Public Spend$1.4M
2024 Medicare Part D Spend$1.2M
2024 Medicaid Spend$253K
Reported Wholesale Price Change (CA SB 17)8 WAC filings (max 21.1% 2-yr change)